BGM Group Ltd.
NASDAQ: BGM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chen Xin
- Employees
- 298
- Headquarters
- Chengdu, China
- IPO year
- 2003
- Market cap
- $68.5M
- Website
- https://www.bgm.ltd
Loading BGM…
Loading profile data…Frequently asked questions about BGM
What does BGM Group Ltd. (BGM) do?
Operating from Chengdu, People's Republic of China, BGM Group Ltd. engages in the manufacturing and supply of active pharmaceutical ingredients (APIs), traditional Chinese medicine (TCM) derivatives, and various other related products across China. The company's pharmaceutical portfolio includes an array of licorice-based items: Gan Di Xin, an o...
Where does BGM trade?
BGM Group Ltd. (BGM) trades on the NASDAQ Global Market.
What sector is BGM in?
BGM Group Ltd. (BGM) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of BGM Group Ltd.?
Chen Xin is the chief executive officer of BGM Group Ltd. (BGM).
Where is BGM Group Ltd. headquartered?
BGM Group Ltd. is headquartered in China.
Does BGM pay a dividend?
BGM Group Ltd. (BGM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BGM go public?
BGM Group Ltd. (BGM) completed its initial public offering in 2003.